Reproductive Hazard Myth vs Reality - PowerPoint PPT Presentation

1 / 70
About This Presentation
Title:

Reproductive Hazard Myth vs Reality

Description:

Used illegally as sleeper in US. Astonishing discovery ... Microcephaly, broad nasal bridge, epicanthal folds, thin upper lip. Fetal alcohol syndrome ... – PowerPoint PPT presentation

Number of Views:57
Avg rating:3.0/5.0
Slides: 71
Provided by: fun9
Category:

less

Transcript and Presenter's Notes

Title: Reproductive Hazard Myth vs Reality


1
Reproductive HazardMyth vs Reality
  • Fred Fung, M.D., M.S.
  • SRSMG, UCSD, UCI

2
Pre-test
  • Female reproductive system
  • ova produced in a womans life time?
  • Male reproductive system
  • days testes need to produce sperms?
  • Placenta
  • Why is heparin safer than coumadin?
  • Fetus
  • Time frame for organogenesis?

3
Overview
  • Medical-legal context
  • Definitions
  • Toxicology principles
  • Lessons from the past
  • Evaluation strategies and Practice guidelines
  • Resources

4
Workforce demographics
  • A gradual shift of workforce demographics over
    the last 2-3 decades
  • 50 women constitute todays workforce
  • Many take up jobs traditionally held by men
  • Most of them in reproductive age

5
Common questions
  • From employee
  • Doctor, am I safe to work here?
  • Is my baby going to be ok if I work with?
  • From employer
  • Is it safe for her to work with?
  • How soon can she return to work?

6
A medical-legal issue
  • 1978 Pregnancy Protection Act and Title VII Civil
    Rights Act of 1964
  • 1982 Johnson Controls Fetal protection policy
    (shifts from warning to exclusion)
  • 1984 UAW v Johnson Controls over prohibiting
    female workers from working with lead

7
(No Transcript)
8
(No Transcript)
9
Legal battles
  • Is it lawful to exclude female employees from
    jobs for hazard concerns over fetus?
  • Lead exposure and potential adverse fetal outcome
    at issue
  • First round Federal District Court
  • Second round Appeals Court
  • Final round US Supreme Court

10
US District Court, 7th Circuit Court-Summary J.
11
What is the core issue?
  • Plaintiff direct violation of PDA
  • Defense Business necessity (safety argument) and
    BFOQ
  • A 3-step decision. Substantial risk to fetus?
    Transmission of hazard via women? Availability of
    less discriminatory alternative?
  • BFOQ condition of employment-sterility

12
1991 Supreme Court-reverses lower courts decisions
13
The final decision
  • US Supreme Court unanimous decision beneficence
    of policy still violates PDA, fetal
    welfare/safety a parental decision, tort remote
    if employer abides by all regs
  • Johnson Controls fetal protection policy is a
    prima facie sex discrimination, thus illegal

14
Scope of problem
  • 4 million live births/y US 2002
  • 120,000 babies with BD each year
  • Baseline 3/100 live births have birth defect
  • Why focus on birth defects?
  • Reproductive injury/fetal loss is generally not
    covered under work comp-why?

15
(No Transcript)
16
Definitions
  • A teratogen is defined as a substance, organism,
    or physical agent to which an embryo or fetus is
    exposed that produces a permanent abnormality in
    structure or function, causes growth retardation,
    or causes death.
  • There are no absolute teratogens
  • Toxicity inherent ability to induce injury
  • Hazard potential of toxicity
  • Risk probability of damage to life/health will
    occur for a given hazard. May include outrage

17
Sources of exposure
  • Occupational 90,000 chemicals in use
  • 45000 tested for teratogenicity
  • 2/3 negative, 1/3 positive or equivocal
  • Only 30 agents documented teratogens
  • Habits and meds 30-70 pregnant women use
    caffeine, alcohol and cigarettes
  • Illicit drugs 15-25 pregnant women use sometime
    during pregnancy- cocaine, MJ

18
Human teratogens
  • Infection TORCH, syphilis
  • Metabolic folate deficiency, DM
  • Medication/drug alcohol, anticonvulsants,
    retinoids, DES, thalidomide, alkylating agents,
    cocaine, cigarette smoking
  • Metals/chemicals Pb, Hg, Cd, DCBP, OCl, EtO,
    anesthetic gases, dioxins, PCB
  • Radiation therapeutic, diagnostic, fallout

19
Severity and frequency
  • Quality- severity, nature of hazard, clinical
    significance
  • Quantity-number at risk, frequency of occurrence,
    statistical significance

20
Importance of severity and frequency
  • Rubella 40-60 birth defect
  • Toxo 10 major birth defect
  • CMV 1-2 major birth defect
  • Alcohol 4-40 FAS
  • DM lt10 good control, 5-35 poor control
  • DBCP12 azoospermia,12 hypospermia
  • Methyl Hg 10 Minamata Bay syndrome
  • Dilantin/valproate 1 fetal hydantoin synd.
  • Folate def 30 NTD

21
FDA classification of drugs
  • A- safety established in human studies, only
    thyroid hormone, folic acid, prenatal vitamins
    (Tylenol under Australian ADEC)
  • B-presumed safety based on animal studies
    (Amoxicillin)
  • C- safety uncertain, no studies (most drugs)
    Celebrex other NSAIDs
  • D- Unsafe, risk benefit analysis needed
    (Tetracycline)
  • X- highly unsafe e.g. Accutane, BCP

22
Occupational smellers-Whats in body odor?
23
Placenta
24
Basic concept
  • Almost all agents can be teratogenic under
    certain circumstances. The dose and time of the
    exposure to a particular agent often determines
    the severity of the damage and the type of damage
    that occurs.
  • Types of teratogens radiation, infections,
    drugs, metabolic disorders and environmental
    chemicals
  • Semin Reprod Med 18(4)407-424, 2000

25
(No Transcript)
26
How does teratogenesis occur?
  • DNA replication may result in incorporation of
    the wrong bases (baseline)
  • DNA exposed to mutagens/teratogens
  • High energy radiation UV, X-rays, radioactivity
  • Chemicals that react or bind to DNA
  • Chemicals which when metabolized generate
    reactive oxygen compounds that damage DNA

27
Toxicology principles
  • Basic principles still apply exposure,
    absorption, distribution, metabolism, elimination
  • Dose-response still holds, i.e. threshold concept
    is good
  • Multi-multi-compartment model
  • Embryo remarkable restorative ability-DNA repair
    and proof-reading

28
(No Transcript)
29
Pharmacokinetic changes
  • Increase in gastric pH, GI transit time, Vd, GFR
  • Decrease in P450 CYP1A2, Protein binding
  • Toxin ? maternal exposure ? maternal factors
    ?placental factors ? fetal factors
  • CYP1A2 drugs caffeine, diazepam, warfarin, TCA

30
Brief history
  • Teratology-relatively new science
  • Teras- Gk for monster
  • Mythology- cyclops, sirens
  • Maternal impression- listening to Mozart or
    looking at beautiful things
  • Late 1800s, 1900s- genetics
  • 1930s- induced birth defects animal study

31
Important historical events
  • 1941- 1st human epidemic of birth defects from a
    natural environmental/infectious agent

32
Rubella
  • 1st, 2nd month gestation infection- heart and eye
  • 3rd month- hearing and speech

33
Rubella cases drop after vaccination starts
34
First drug induced birth defect
  • 1960s- infants with limb abnormalities (Hamburg
    U.)

35
Phocomelia
  • Amelia- absence of limbs
  • Phokos- seal
  • Phocomelia- seal limbs
  • Taussig HB. A study of German outbreak of
    phocomelia (JAMA 1962, 1801106)
  • First 2 cases presented 1960, no attention
  • All physicians knew about it by 1962

36
(No Transcript)
37
Thalidomide
  • Ciba developed it as anticonvulsant, worthless
    but caused sedation
  • Found no fetal effects on animals (rodents)
  • Marketed as sedative for mental patients
  • Sold as OTC, 3rd best selling drug in Europe
  • Used illegally as sleeper in US

38
Astonishing discovery
  • Dr. Francis Kelsey, new physician scientist given
    drug application on Thalidomide as her first
    assignment 9/12/1960
  • Told an easy project, not to be so!
  • Found side effects of peripheral neuritis,
    concerned about fetal effects- no data
  • Never approved for pregnancy use

39
Thalidomide
  • Gestational time critical
  • 40-44 days most sensitive time
  • Hypothesis- inhibits angiogenesis
  • down regulates adhesion receptors
  • reduces phagocytosis of PMNs

40
More about Thalidomide
  • Approved by FDA July 16, 1998
  • Current indications erythema nodosum leprosum
    with disfiguring lesions
  • Also for aphthous stomatitis, graft v host,
    multiple myeloma
  • Must be in STEPS (System for Thalidomide
    Education, Prescription Safety) program

41
Why didnt rodents show defects?
  • Thalidomide poorly absorbed by rodents PO
  • Human more sensitive to teratogenic effects of
    thalidomide

42
Acne and teenager
  • Tragic combination if Accutane used in early
    pregnancy
  • 1st reported 1954, offsprings from female rats
    fed with high Vit A had birth defects
  • Similar cells affected as in FAS
  • Cardiovascular- tetralogy of Fallot, VSD
  • Most sensitive 3-5 weeks gestation

43
Chemical Structures of (a) Vitamin A (b)
Isotretinoin
a) Vitamin A is formed by carboxylation of the
aldehyde group (OH). b) Isotretinoin is also
called 13-cis retinoic acid.
44
Isotretinoin Malformation
Source Jones KL. Smiths Recognizable Patterns
of Human Malformation, 5th Ed. London W.B.
Saunders, 1996.
45
Isotretinoin Deformity
Source Jones KL. Smiths Recognizable Patterns
of Human Malformation, 5th Ed. London W.B.
Saunders, 1996.
46
Retinoic acid
  • FDA 12/31/2005
  • iPLEDGE program
  • Prescriber and user must register
  • 2 neg preg tests prior to filling Rx
  • Each month must enter by internet or phone 2
    types of BC while on Rx and one month after

47
Other teratogens
  • Infectious agents TORCH
  • Metabolic DM, alcoholism
  • Drugs warfarin, antiepileptics, cocaine
  • Heavy metals Pb, Cd, Hg
  • Radiation

48
FAS
  • Growth retardation
  • CNS degeneration
  • Simian crease on palms
  • Facial dysmorphology
  • Microcephaly, broad nasal bridge, epicanthal
    folds, thin upper lip

49
Fetal alcohol syndrome
  • First described by Lemoine 1968
  • Landmark paper Lancet 1973

50
Normal vs FAS brain
51
FAS
  • Zinc theory- maternal Zn def, impaired zinc
    metalloenzymes (aldehyde dehydrogenase), impaired
    fetal growth (protein synthesis)
  • Other factors timing, nutrition, genetics Not
    100 heavy pregnant drinkers beget FAS babies

52
Minamata Bay
  • Inorganic mercury from plastics factory discharge
    into downstream bay, converted by bacteria into
    methyl mercury
  • Cats ate fish had unsteady gait
  • Mothers had no obvious symptoms
  • Babies had congenital abnormalities
  • CP, mental retardation, microcephaly

53
(No Transcript)
54
Folic acid deficiency-neural tube
55
Warfarin
  • 1st described in 1980 case series
  • Nasal hypoplasia, short fingers, stippled
    epiphyses. No effect on clotting factors.
  • Crosses placenta, embryo Vit K deficient
  • Inh Vit K ? inhibits GLA proteins (osteocalcins)
    in bone/cartilage
  • Abn cartilage growth/calcification similar to
    Chondrodysplasia punctata genetic defect

56
Antiepileptics/anticonvulsants
  • Maternal seizure in 1st trimester-risk per se
  • Fetal hydantoin syndrome- hypoplasia of
    nails/fingers, digitized thumb, hirsutism
  • Orofacial defects-low nasal bridge, bowed upper
    lip, cleft lip/palate
  • Epoxides bind with fetal nucleic acids
  • Epoxide hydrolase activities differ
  • Inh K channel-bradycardia, fetal hypoxia

57
Diagnostic strategies
  • Medical history
  • Symptoms and signs
  • Hobby, family and genetic history
  • Partner history
  • Physical exam
  • Tests
  • Prenatal tests
  • Work place surveillance

58
What caused my baby to have a birth defect?
  • Scientific causation analysis
  • What exact birth defect is it X?
  • Can this substance Y cause birth defect?
  • Did Y cause X?

59
Reproductive hazard management
  • Hazard elimination and exposure control
  • Exposure control monitoring
  • Risk no absolute risk free
  • Risk Communication put in perspective
  • Require notification of pregnancy
  • Temporary reassignment

60
Practical Approach
  • Approach issues scientifically, allows
    operational manager to make risk management
    decisions
  • If work is risk, then re-assignment
  • Avoid unneeded drugs and unnecessary chemical,
    radiological and viral exposures
  • When in doubt/outrage, spend time on risk
    communication
  • Early referral to high risk OB doctor if exposure
    significant

61
Set reasonable Policy Procedures
  • Legal review- to ensure compliance of Fed/State
    laws
  • Employee to notify- HR/OHS of any medical
    condition including pregnancy so safe duty
    placement can be made
  • Employee may be offered- other available duties
    for which she is qualified
  • Counseling- EAP to alleviate unnecessary fears

62
Issues to keep in mind
  • Innumeracy vs illiteracy
  • Heuristics vs emotion
  • Feeling about risk is more important to patient
    than evidence

63
Innumeracy
  • Numbers dont mean anything to people having
    reproductive concerns
  • Risk between 0-1 is over-estimated
  • Not all frequencies are equal 1/10 is less
    impressive than 100/1000
  • Baseline or background rates irrelevant
  • Most people believe 80/1000 carries a higher
    chance than 1/10

64
Heuristics-looking for guidance
  • Information availability-media (one case all
    cases)
  • Similarity of case (my friend had it!)
  • Initial diagnosis by primary care physician
    (fixation on first impression)
  • Persuasion not scientific content (messenger
    credibility, multiple weak arguments,
    audio-visual appeal)

65
Remember the Donts
  • Dont make extreme decisions
  • Dont make decisions yourself-team
  • Dont sell science/stats to employees
  • Dont forget to collect some evidence
  • Dont ignore examples
  • Examples of good outcome (employee likely
    admires/accepts the person or gp)

66
Emotion is everything at first
  • Beware of anxiety and depression-almost always
    negative and pessimistic view
  • Happiness and anger-good predictors
  • Rationality veneer-compromise represents reasoned
    decision
  • Recall bias-impact on judgment, belief
  • Social comparison-how do I compare with (RR or
    AR not pertinent)
  • Share bad news early-no surprises

67
Bottom line
  • Avoid drugs and unnecessary chemical,
    radiological and viral exposures
  • Try how do you feel about our discussion
  • I feel good for you that risk is negligible
  • When in doubt, offer alternative job duties

68
Closing remarks
  • Complex and emotional issues
  • Many chemicals and drug dont have complete
    toxicological data
  • Suspicions justified but not as facts unless
    specific data available
  • Specific about dangers but not to condemn all
    drugs/chemicals as fetotoxic
  • Examples are more persuasive

69
Main Resources
  • Centers for Disease Control Division of
    Reproductive Health www.cdc.gov/reproductivehealt
    h/index.htm
  • Organization of Teratology Information Services
    (OTIS) www.otispregnancy.org
  • Reprotox www.reprotox.org
  • TETRIS (Teratogen Information System)
    http//depts.washington.edu/terisweb
  • FDA www.fda.gov/womens

70
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com